Recent Security Class Actions

Fulcrum Therapeutics Inc. Common Stock (NASDAQ: FULC)

Company Name:Fulcrum Therapeutics Inc. Common Stock
Stock Symbol:NASDAQ: FULC
Class Period Start:03/03/2022
Class Period End (inclusive):03/08/2023
Filing Deadline:06/27/2023

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s FDA operations and compliance policies. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) the preclinical data submitted in support of FTX-6058 showed safety concerns regarding potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would place a clinical hold on preclinical studies of FTX-6058; (iii) accordingly, the Company had overstated FTX-6058’s clinical and/or commercial prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.